Suppr超能文献

糖皮质激素替代疗法:过去、现在与未来。

Glucocorticoid replacement therapies: past, present and future.

作者信息

Liew Su-Yi, Akker Scott A, Guasti Leonardo, Pittaway James F H

机构信息

Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

出版信息

Curr Opin Endocr Metab Res. 2019 Oct;8:152-159. doi: 10.1016/j.coemr.2019.08.011. Epub 2019 Sep 4.

Abstract

Since the original description of adrenal insufficiency by Thomas Addison in 1855, there has been an exponential growth in the understanding of adrenal gland biology and its role in the hypothalamic-pituitary-adrenal axis. Despite this, the mainstay of therapeutic glucocorticoid replacement for most clinicians has remained unchanged for nearly 50 years. More recently, there has been better recognition of the morbidity and mortality associated with current approaches and the challenges to tackle in reducing this and improving clinical outcomes. In this review, we have summarised the history of glucocorticoid replacement therapy from its nascence in the 1930s, through common practice and culminating in more recent glucocorticoid replacement strategies plus the potential of stem cell therapy in the future.

摘要

自1855年托马斯·艾迪生首次描述肾上腺功能不全以来,人们对肾上腺生物学及其在下丘脑-垂体-肾上腺轴中的作用的理解呈指数级增长。尽管如此,近50年来,大多数临床医生进行治疗性糖皮质激素替代的主要方法一直没有改变。最近,人们越来越认识到当前方法所带来的发病率和死亡率,以及在降低这些风险和改善临床结果方面所面临的挑战。在这篇综述中,我们总结了糖皮质激素替代疗法的历史,从20世纪30年代的诞生,到常见的治疗方法,再到最近的糖皮质激素替代策略,以及未来干细胞疗法的潜力。

相似文献

1
Glucocorticoid replacement therapies: past, present and future.
Curr Opin Endocr Metab Res. 2019 Oct;8:152-159. doi: 10.1016/j.coemr.2019.08.011. Epub 2019 Sep 4.
5
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
Clin Endocrinol (Oxf). 2019 Jan;90(1):3-14. doi: 10.1111/cen.13837. Epub 2018 Sep 24.
6
Management of steroid replacement in adrenal insufficiency.
Minerva Endocrinol. 2010 Jun;35(2):61-72.
8
Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
J Clin Endocrinol Metab. 2012 Oct;97(10):E1938-42. doi: 10.1210/jc.2012-2432. Epub 2012 Aug 7.
9
Optimal glucocorticoid replacement in adrenal insufficiency.
Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):3-15. doi: 10.1016/j.beem.2014.09.009. Epub 2014 Oct 7.
10
Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis.
Endocrine. 2021 Oct;74(1):29-37. doi: 10.1007/s12020-021-02723-z. Epub 2021 Apr 12.

本文引用的文献

1
Prednisolone Replacement Therapy Mimics the Circadian Rhythm More Closely Than Other Glucocorticoids.
J Appl Lab Med. 2016 Sep 1;1(2):152-161. doi: 10.1373/jalm.2016.020206.
2
Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies.
Int J Mol Sci. 2019 May 24;20(10):2560. doi: 10.3390/ijms20102560.
3
Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study.
J Clin Endocrinol Metab. 2018 Aug 1;103(8):2998-3009. doi: 10.1210/jc.2018-00346.
4
Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations.
Clin Endocrinol (Oxf). 2018 Jul;89(1):30-35. doi: 10.1111/cen.13609. Epub 2018 Apr 22.
5
Ultradian rhythmicity of plasma cortisol is necessary for normal emotional and cognitive responses in man.
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4091-E4100. doi: 10.1073/pnas.1714239115. Epub 2018 Apr 9.
8
Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma.
Eur J Endocrinol. 2017 Sep;177(3):251-256. doi: 10.1530/EJE-17-0340. Epub 2017 Jun 8.
10
Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency.
J Clin Endocrinol Metab. 2016 Dec;101(12):4843-4850. doi: 10.1210/jc.2016-2221. Epub 2016 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验